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Purpose
To estimate the current cancer burden in Korea, cancer incidence and mortality were pro-
jected for the year 2011.
Materials and Methods
The cancer incidence data from 1999-2008 were obtained from the Korea National Cancer
Incidence Database, and the cancer mortality data from 1993-2009 were obtained from the
Korea National Statistics Office. Cancer incident cases and rates in 2011 were projected
from fitting a linear regression model on observed age-specific cancer incidence rates against
observed years, then multiplying the projected age-specific rates by the age-specific population.
For cancer mortality, a similar procedure was applied for projection except that a Joinpoint
regression model was used to determine at which year the linear trend significantly changed. 
Results
A total of 216,809 new cancer cases and 71,036 cancer deaths are projected to occur in
Korea in 2011. For all sites combined, the crude incidence rates are projected to be 437.9 and
420.5 and the age-standardized incidence rates are projected to be 336.5 and 279.7 per
100,000 for men and women, respectively.
Conclusion
Cancer has become an important public health concern in Korea, and as Korea becomes an
aged society, the cancer burden will continue to increase.
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Introduction
Having been the leading cause of death since 1983 [1], cancer has
become a major public health concern in Korea. Annually, over
170,000 patients are newly diagnosed with cancer in Korea and one
out of four deaths is due to cancer [2,3]. While the cancer regist-
ration system in Korea is very efficient and can provide the nationwide
cancer statistics within a relatively short time, at least a 2-year lag
time behind the current year is still needed because of the time
required for data collection and compilation. In order to plan and
apply a cancer control program for the current year, it is important to
assess the number of new cancer cases and cancer deaths that are
expected to occur during the current year. In this report, we provide
the projected cancer incidence and mortality on the basis of
observed data of up to year 2008. Kyu-Won Jung, et al_Prediction of Cancer Incidence and Mortality in Korea, 2011
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Materials and Methods
The Korea Ministry of Health and Welfare initiated a nationwide,
hospital-based cancer registry (the Korea Central Cancer Registry
[KCCR]) in 1980. The details of the history, objectives, and
activities of the KCCR have been documented [4]. Incidence data
from 1999-2008 were obtained from the Korea National Cancer
Incidence Database (KNCI DB). Cancer cases were classified ac-
cording to the International Classification of Diseases for Oncology,
3rd edition [5] and converted according to the International Classi-
fication of Diseases, 10th edition (ICD-10) [6]. 
Mortality data from 1993-2009 were obtained from the Korea
National Statistics Office (KNSO) [1]. The cause of death was
coded and classified according to ICD-10. 
The cancer sites included in this report are all cancers combined
and 22 common cancers: lip, mouth, and pharynx (C00-C14), eso-
phagus (C15), stomach (C16), colon and rectum (C18-C20), liver
and intrahepatic bile duct (liver) (C22), gallbladder and other parts
of the biliary tract (gallbladder) (C23-C24), pancreas (C25), lung
and bronchus (lung) (C33-C34), breast (C50), uterine cervix (C53),
uterine corpus (C54), ovary (C56), prostate (C61), testis (C62), kidney
(C64), bladder (C67), brain and central nervous system (C70-C72),
thyroid (C73), Hodgkin lymphoma (C81), non-Hodgkin lymphoma
(C82-C85, C96), multiple myeloma (C90), leukemia (C91-C95),
and all others.
The population data were obtained from the resident registration
population at the KNSO. The mid-year population on July 1 of the
respective year was applied when computing the incident cases,
deaths, and rates.  
Because the most recent year for which incidence and mortality
data are available is usually 2-3 years behind the current year due to
the time required for the data collection and analysis, we projected
the expected number of new cancer cases and deaths in Korea of the
current year to provide an estimate of the current cancer burden. 
Linear regression models [7] were used to assess the time trend and
the projection of rates. Based on the observed cancer incidence data,
a linear regression model was fitted to the age-specific rates by 5-
year age group against years. From the projected age-specific rates
in 2011, the number of estimated cancer incident cases was calculated
by multiplying the rates by age-specific population size in 2011. For
thyroid and prostate cancer that showed significant curve-linear trends,
Sites
Estimated new cases Estimated deaths
Both sexes  Male Female Both sexes  Male Female
All sites 216,809  110,823 105,986 71,036  44,589  26,447 
Lip, oral cavity, and pharynx 2,712  2,037  675  1,025 758  267 
Esophagus 2,255  2,058  197  1,269  1,174  95 
Stomach 31,036  21,075  9,961  8,955  5,855  3,100 
Colon and rectum 29,766  18,063  11,703 7,765  4,375  3,390 
Liver 16,687  12,443  4,244  10,989  8,240  2,749 
Gallbladder
a) 5,232  2,579  2,653  3,785  1,814  1,971 
Pancreas 5,175  2,801  2,374  4,420  2,331  2,089 
Larynx 1,040  997  43  258  236  22 
Lung 21,902  15,496  6,406  15,769  11,578  4,191 
Breast 15,418  62  15,356  2,081  18  2,063 
Cervix uteri 3,359  - 3,359 841  -  841 
Corpus uteri 1,899  -  1,899  248  -  248 
Ovary 2,104  -  2,104  945  -  945 
Prostate 9,526  9,526  -  1,462  1,462  - 
Testis 202  202  -  20  20  - 
Kidney 3,966  2,731  1,235 792  514  278 
Bladder 3,915  3,153  762  948  687  261 
Brain and CNS 1,809  961  848  1,020  552  468 
Thyroid 38,119  5,756  32,363  360  106 254 
Hodgkin lymphoma 235  145  90  43  27  16 
Non-Hodgkin lymphoma 4,195  2,338  1,857  1,428  842 586 
Multiple myeloma 1,138 581  557  773  387 386 
Leukemia 2,774  1,555  1,219  1,631  939  692 
Other and ill-defined 12,345 6,264  6,081  4,209 2,674  1,535 
Table 1. Estimated new cancer cases and deaths by sex during 2011 in Korea
CNS, central nervous system. 
a)Includes gallbladder and other/unspecified parts of the biliary tract.Cancer Res Treat. 2011;43(1):12-18
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Sites
Crude incidence rates/100,000 Age-standardized incidence rates/100,000
a)
Both sexes Male Female Both sexes Male Female
All sites 429.2  437.9  420.5  297.3  336.5  279.7 
Lip, oral cavity, and pharynx 5.4  8.0  2.7  3.8  6.1  1.9 
Esophagus 4.5  8.1  0.8  3.0  6.3  0.4 
Stomach 61.4  83.3  39.5  41.7  62.9  24.4 
Colon and rectum 58.9  71.4  46.4  40.1  54.2  28.4  
Liver 33.0  49.2  16.8  22.6  36.6  10.2 
Gallbladder
b) 10.4 10.2 10.5 6.7  7.9  5.7 
Pancreas 10.2 11.1 9.4  6.7  8.5  5.2 
Larynx 2.1  3.9  0.2  1.4  3.0  0.1 
Lung 43.4  61.2  25.4  28.3  47.3  14.5 
Breast 30.5  0.2  60.9  21.3  0.2  42.2 
Cervix uteri 6.6  -  13.3  4.6  -  8.9 
Corpus uteri 3.8  -  7.5  2.6  -  5.1 
Ovary 4.2  -  8.3  3.0  -  5.9 
Prostate 18.9 37.6  -  12.6 29.5  - 
Testis 0.4  0.8  -  0.4  0.8  - 
Kidney 7.9  10.8 4.9  5.6  8.1  3.3  
Bladder 7.8  12.5  3.0  5.1  9.6  1.6 
Brain and CNS 3.6  3.8  3.4  3.1  3.4  2.8  
Thyroid 75.5  22.7 128.4 54.3  16.5 92.5  
Hodgkin lymphoma 0.5  0.6  0.4  0.4  0.5  0.3 
Non-Hodgkin lymphoma 8.3  9.2  7.4  6.1  7.4  5.1 
Multiple myeloma 2.3  2.3  2.2  1.5  1.8  1.4 
Leukemia 5.5  6.1  4.8  5.1  5.9  4.4 
Other and ill-defined 24.4  24.7  24.1  17.5  20.1  15.4 
Table 2. Estimated crude and age-standardized cancer incidence rates by sex during 2011 in Korea
CNS, central nervous system.
a)Age adjusted to the World Health Organization (WHO) world standard population, 
b)Includes gallbladder and other/unspecified parts of biliary tract.
we used a square root transformation when fitting a linear regression
model and converted the predicted values back to the original scale. 
To estimate the number of cancer deaths in 2011, we first ran a
Joinpoint regression model on the data from 1993-2009 to detect the
year of significant changes in the trend of cancer mortality separately
by sex and cancer site. A Joinpoint regression describes the changes
in data trends by connecting several different line segments on a log
scale at “joinpoints.” This analysis was performed using Joinpoint
software (version 3.3, http://srab.cancer.gov/joinpoint) from the
Surveillance Research Program of the National Cancer Institute in
the US [8]. After identifying the year of significant trend changes
from a Joinpoint regression analysis, a simple linear regression
model was fitted to the last line segment to estimate age-specific
cancer mortality rates in 2011. Similar to the method used for the
projection of cancer incidence, the number of new deaths was then
projected by multiplying the age-specific cancer mortality rates by
respective age-specific population.
We summarized the results using the crude rates (CRs) and age-
standardized rates (ASRs) of cancer incidence and mortality. The
ASRs were standardized using the World Health Organization (WHO)
world standard population [9]. 
Results
1 Incidence
Table 1 presents the estimated number of new cancer cases and
deaths during 2011 in Korea by sex and cancer site. It is projected
that 216,809 cancer incident cases will occur during the year 2011.
Table 2 presents the estimated CRs and ASRs of cancer incidence
in 2011 by sex and cancer site. The CRs of all sites combined in
2011 are projected to be 437.9 and 420.5 per 100,000 in men and
women, respectively, and the ASRs of all sites combined are pro-
jected to be 336.5 and 279.7 per 100,000. In males, the five leading
primary sites of cancer are expected to be the stomach (CR, 83.3;
ASR, 62.9), colon and rectum (CR, 71.4; ASR, 54.2), lung (CR,
61.2; ASR, 47.3), liver (CR, 49.2; ASR, 36.6), and prostate (CR,
37.6; ASR, 29.5), accounting for 69.1% of all newly diagnosed can-
cers in 2011. In females, the most common cancer sites are expected
to be thyroid (CR, 128.4; ASR, 92.5), breast (CR, 60.9; ASR, 42.2),
colon and rectum (CR, 46.4; ASR, 28.4), stomach (CR, 39.5; ASR,
24.4), lung (CR, 25.4; ASR, 14.5), and liver (CR, 16.8; ASR, 10.2),Kyu-Won Jung, et al_Prediction of Cancer Incidence and Mortality in Korea, 2011
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accounting for 75.5% of all newly diagnosed cancers (Fig. 1).
Thyroid cancer alone is projected to account for 30.5% (32,363
cases) of incident cases in women in 2011.
Table 3 presents the most common cancer sites expected in 2011
by sex and age group. Leukemia and thyroid cancer will be the most
common forms of cancer in both sexes 0-14 and 15-34 years of age,
respectively. Gastric cancer is predicted to be the most common
cancer in males 35-64 years of age, while lung cancer is predicted to
be more frequent for males≥65 years of age. The most common
sites of cancer will be thyroid for females 35-64 years of age, while
colorectal cancer will be the most common cancer for females≥65
years of age. 
Fig. 2 shows the age-specific incidence rates of selected cancers
for men and women in 2011. The projection indicates that the inci-
dence of gastric, lung, liver, and colorectal cancers increases gradually
with age. In women, the age-specific incidence rates of breast and
thyroid cancer will increase with age until the 5th and 6th decades of
life, then level off.
2 Mortality
It is estimated that 71,036 cancer deaths will occur during 2011
(Table 1). The CRs of all sites combined in 2011 are projected to
become 176.2 and 104.9 per 100,000 for men and women, respec-
tively, and the ASRs of all sites combined are expected to be 136.6
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Fig. 1. Ten leading cancer types for the estimated new cancer cases and deaths by sex in 2011. (A) Estimated new cases. (B) Estimated deaths.Cancer Res Treat. 2011;43(1):12-18
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Rank
Age group (yr)
0-14 15-34 35-64 ≥65
Male
1 Leukemia Thyroid Stomach Lung
(4.7) (10.0) (94.8) (480.5)
2 Brain and CNS Leukemia Colon and rectum Stomach
(2.4) (3.3)  (80.4) (449.1)
3 Non-Hodgkin lymphoma Non-Hodgkin lymphoma Liver Colon and rectum
(1.8) (2.8) (66.7) (387.7)
4 Kidney Colon and rectum Lung Prostate
(0.6) (2.6) (41.1) (314.2)
5 Testis/Liver Stomach Thyroid Liver
(0.3) (2.5) (38.8) (210.0)
Female
1 Leukemia Thyroid Thyroid Colon and rectum
(4.2) (57.4) (230.0) (191.4)
2 Brain and CNS Breast Breast Stomach
(2.1) (10.7) (113.7) (152.4)
3 Non-Hodgkin lymphoma Cervix uteri Colon and rectum Lung
(0.9) (4.5) (47.2) (126.8)
4 Ovary Stomach Stomach Thyroid
(0.7) (4.5) (41.8) (81.5)
5 Kidney Ovary Lung Liver
(0.6) (2.8) (19.9) (75.9)
Table 3. Estimated cancer incidence by age group and sex during 2011 in Korea
CNS, central nervous system.
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Fig. 2. Age-specific cancer incidence rates of major cancers during 2011 in Korea. (A) Male. (B) Female.
and 58.3 per 100,000 for men and women, respectively (Table 4).
In men, the five leading primary cancer sites for mortality in 2011
are predicted to be lung (CR, 45.7; ASR, 41.2), liver (CR, 32.6;
ASR, 29.9), stomach (CR, 23.1; ASR, 17.3), colon and rectum (CR,
17.3; ASR, 13.3), and pancreas (CR, 9.2; ASR, 7.3). In women,
lung cancer (CR, 16.6; ASR, 9.4) is projected to be the leading
cancer site for mortality in 2011, followed by cancers of the colon
and rectum (CR, 13.4; ASR, 7.4), stomach (CR, 12.3; ASR, 9.7),
liver (CR, 10.9; ASR, 7.5), and gallbladder (CR, 7.8; ASR, 4.4). 
Fig. 3 shows the age-specific mortality rates of the selected cancers
for men and women in 2011. When examined by age, liver cancer is
expected to have the highest mortality rates in Korean men up to 60Kyu-Won Jung, et al_Prediction of Cancer Incidence and Mortality in Korea, 2011
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years of age, followed by lung cancer. In contrast, breast cancer is
expected to have the highest mortality rates in Korean women up to
55 years of age, followed by lung cancer. 
Sites
Crude mortality rates/100,000 Age-standardized mortality rates/100,000
a)
Both sexes Male Female Both sexes Male Female
All sites 140.6  176.2  104.9 90.9  136.6  58.3 
Lip, oral cavity, and pharynx 2.0  3.0  1.1 1.3  2.2  0.5 
Esophagus 2.5  4.6  0.4  1.6  3.6  0.3 
Stomach 17.7  23.1  12.3  11.2  17.3  9.7 
Colon and rectum 15.4  17.3 13.4  9.8  13.3  7.4 
Liver 21.8  32.6  10.9  14.6  29.9  7.5 
Gallbladder
b) 7.5  7.2  7.8  4.6  6.8  4.4 
Pancreas 8.7  9.2  8.3  5.6  7.3  4.2 
Larynx 0.5  0.9  0.1  0.3  1.9  0.1 
Lung 31.2  45.7  16.6  19.8  41.2  9.4 
Breast 4.1  0.1  8.2  2.8  0.1  4.8 
Cervix uteri 1.7  -  3.3  1.1  -  2.8 
Corpus uteri 0.5  -  1.0  0.3  -  0.4 
Ovary 1.9  -  3.7  1.2  -  2.1 
Prostate 2.9  5.8  -  1.7  4.5  - 
Testis 0.0  0.1  -  0.0  0.0  - 
Kidney 1.6  2.0  1.1  1.0  1.8  0.5 
Bladder 1.9  2.7  1.0  1.1  2.9  0.5 
Brain and CNS 2.0  2.2  0.9  1.5  2.3  1.7 
Thyroid 0.7  0.4  1.0  0.4  0.4  0.6 
Hodgkin lymphoma 0.1  0.1  0.1  0.1  0.1  0.0 
Non-Hodgkin lymphoma 2.7  3.3  2.3  1.9  2.8  1.4 
Multiple myeloma 1.5  1.5  1.5  1.0  1.1  0.7 
Leukemia 3.2  3.7  2.7  2.4  3.3  1.9 
Other and ill-defined 8.3  10.6 6.1  5.4  7.0  4.1 
Table 4. Estimated crude and age-standardized cancer mortality rates by sex during 2011 in Korea
CNS, central nervous system.
a)Age adjusted to the World Health Organization (WHO) world standard population, 
b)Includes gallbladder and other/unspecified parts of biliary tract. 
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Fig. 3. Age-specific cancer mortality rates of major cancers during 2011 in Korea. (A) Male. (B) Female.Cancer Res Treat. 2011;43(1):12-18
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Conclusion
This report provides the estimated nationwide cancer incidence
and mortality in Korea in the current year. There are 216,809 cancer
cases and 71,036 cancer deaths expected during 2011 in Korea. In
Korean men, gastric, colorectal, lung, liver, and prostate cancers are
estimated to be the most common incident cancers, and lung, liver,
gastric, colorectal, and pancreatic cancers are estimated to be the
most common cancer-related deaths. In Korean women, thyroid,
breast, gastric, colorectal, and lung cancer are estimated to be the
most common incident cancers and lung, colorectal, stomach, liver,
and gallbladder cancers are the most common cancer-related deaths.
Cancer has become an important public health concern in Korea,
and as Korea becomes an aged society, the cancer burden will
continue to increase. The estimated cancer statistics of the current year
in this report can be used as an important source to plan and evaluate
the cancer control programs in Korea. The estimates in this report,
however, are projected numbers based on statistical models which
may vary from year-to-year, hence these estimates should be used
with caution. 
Conflicts of Interest
Conflict of interest relevant to this article was not reported.
Acknowledgments
This work was supported by a research grant from the National
Cancer Center (No. 1010160), and a National Health Promotion
Program grant (No. 1060300) from the Ministry for Health, Welfare
and Family Affairs, Republic of Korea.
1. National Statistical Office [Internet]. Daejeon: National Statistical Office; 2011 [cited
2011 Jan 14]. Available from: http://kostat.go.kr.
2. Ministry for Heath, Welfare and Family Affairs. 2008 Annual report of cancer statistics
in Korea. Seoul: Ministry for Heath, Welfare and Family Affairs; 2010.
3. Won YJ, Sung J, Jung KW, Kong HJ, Park S, Shin HR, et al. Nationwide cancer
incidence in Korea, 2003-2005. Cancer Res Treat. 2009;41:122-31.
4. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer
incidence in Korea, 1999~2001: first result using the national cancer incidence
database. Cancer Res Treat. 2005;37:325-31.
5. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin D, et al. International
classification of diseases for oncology. 3rd ed. Geneva: World Health Organization; 2000. 
6. World Health Organization. Manual of the international statistical classification of
diseases, injuries, and causes of death. 10th rev. Geneva: World Health Organization; 1992.
7. Boyle P, Parkin DM. Statistical methods for registries. In: Jensen OM, Parkin DM,
MacLennnan R, Muir CS, Skeet RG, editors. Cancer registration: principles and
methods. IARC Scientific Publication No. 95. Lyon: IARC; 1991. p. 126-58.
8. National Cancer Institute. Joinpoint Regression Program, version 3.3 [Internet].
Bethesda: National Cancer Institute; 2011 [cited 2011 Jan 6]. Available from:
http://srab.cancer.gov/joinpoint/. 
9. Segi M. Cancer Mortality for selected sites in 24 countries (1950-1957). Sendai: Tohoku
University School of Medicine; 1960.
References